Cemiplimab treatment of recurrent cervical cancer is associated with longer overall survival | 2 Minute Medicine
2 Minute Medicine ,
1. Overall survival is longer in patients treated with cemiplimab as compared to chemotherapy.
Innovations in the Management of Advanced Cervical Cancer: Focus on Multidisciplinary Care
OncLive,
The management of carcinoma of the cervix represents a remarkable dichotomy. On the one hand, we have the well-established…
Bevacizumab Benefit in Large-Volume Ovarian Cancer
Medscape,
Hopes that extended antiangiogenesis exposure with bevacizumab (multiple brands) might stave off tumor growth more effectively…